We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Castle Biosciences announced the results today, and the results show that the DecisionDx®-Melanoma Gene Expression Profiling (GEP) assay using the American Cancer Joint Committee (AJCC) staging can improve...